Levee Medical(R) , a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its ...

In general, prophylaxis for urologic surgery should be discontinued within 24 hours, and in many cases, a single dose is appropriate. Although common practice has been to administer agents longer when ...

!–paging_filter–pUrologists diagnose and treat disorders of the urinary tract, prostate and bladder, such as urinary tract infections, prostate cancer and incontinence./p pstrongEmily B. Bradley, M.D.

Fred Hutchinson Cancer Center recently became one of only a few centers in the Pacific Northwest to acquire the da Vinci single-port robotic surgical system. Adding this new technology to its fleet of ...

A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.

Urology, Ramaiah Institute of Nephro-Uro Sciences, Ramaiah Memorial Hospital, explains how robotic and minimally invasive ...

A surgeon who devoted his career to drive innovation in urologic cancer diagnosis and treatment will lead urology at Northwell Health. Dr. Samir Taneja, who was appointed to the position after a ...

ALBANY, N.Y. (NEWS10) — Albany Medical Center urologists published a study that concluded patients who had received major abdominal/pelvic surgery rarely needed prescription opioids for pain after ...

Dr. Wallis is a Clinical Professor of Surgery in the Division of Urology at the University of Utah and Chief of Pediatric Urology at Primary Children’s Hospital. He is a board certified pediatric ...

Urologists are surgeons who diagnoses and treat disorders of the urinary tract, such as urinary tract infections and incontinence. They also treat cancer of the bladder, kidneys, prostate and testes.

Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its Voro® ...